0001179110-20-001422.txt : 20200210 0001179110-20-001422.hdr.sgml : 20200210 20200210192445 ACCESSION NUMBER: 0001179110-20-001422 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200206 FILED AS OF DATE: 20200210 DATE AS OF CHANGE: 20200210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Neidig Brent CENTRAL INDEX KEY: 0001775522 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35024 FILM NUMBER: 20593414 MAIL ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. CITY: WEST VALLEY CITY STATE: UT ZIP: 84120 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: USANA HEALTH SCIENCES INC CENTRAL INDEX KEY: 0000896264 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 870500306 STATE OF INCORPORATION: UT FISCAL YEAR END: 1228 BUSINESS ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 BUSINESS PHONE: 8019547100 MAIL ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. STREET 2: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 FORMER COMPANY: FORMER CONFORMED NAME: USANA INC DATE OF NAME CHANGE: 19930125 4 1 edgar.xml FORM 4 - X0306 4 2020-02-06 0 0000896264 USANA HEALTH SCIENCES INC USNA 0001775522 Neidig Brent 3838 WEST PARKWAY BLVD. WEST VALLEY CITY UT 84120 0 1 0 0 Chief Officer & MD of China Common Stock 2020-02-06 4 M 0 283 A 1957 D Common Stock 2020-02-06 4 F 0 126 80.71 D 1831 D Common Stock 2020-02-06 4 M 0 783 70.745 A 2614 D Common Stock 2020-02-06 4 S 0 783 79.00 D 1831 D Common Stock 2020-02-06 4 M 0 1420 65.255 A 3251 D Common Stock 2020-02-06 4 S 0 1420 80.50 D 1831 D Restricted Stock Units 2020-02-06 4 M 0 283 0 D Common Stock 283 13631 D Stock - Settles Stock Appreciation Right 70.745 2020-02-06 4 M 0 7500 0 D 2019-09-01 2020-03-01 Common Stock 7500 0 D Stock - Settles Stock Appreciation Right 65.255 2020-02-06 4 M 0 7500 0 D 2019-11-03 2020-06-03 Common Stock 7500 0 D Each restricted stock unit represents a contingent right to receive one share of USNA common stock. On May 1st, 2017, the reporting person was granted restricted stock units, vesting at 25% on each 6th of February thereafter. The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II. Joshua Foukas, as attorney in fact. 2020-02-10